INBX
Inhibrx Biosciences Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$68.74
-0.56 ▼ -0.81%
🌙 3월 13일 5:33 PM ET (한국 3/14 06:33)
$70.00
+1.26 ▲ +1.83%
| Index | RUT | P/E | - | EPS (ttm) | -10.24 | Insider Own | 30.02% | Shs Outstand | 0.01B | Perf Week | -0.64% |
| Market Cap | 1.00B | Forward P/E | - | EPS next Y | 47.17% | Insider Trans | -7.42% | Shs Float | 0.01B | Perf Month | -16.16% |
| Enterprise Value | 0.95B | PEG | - | EPS next Q | -2.08 | Inst Own | 76.13% | Short Float | 16.97% | Perf Quarter | -18.66% |
| Income | -0.16B | P/S | 714.1 | EPS this Y | -108% | Inst Trans | 28.98% | Short Ratio | 8.21 | Perf Half Y | 141.62% |
| Sales | 0.00B | P/B | 27.06 | EPS next 5Y | - | ROA | -77.54% | Short Interest | 1.73M | Perf YTD | -12.99% |
| Book/sh | 2.54 | P/C | 6.53 | EPS past 3/5Y | - | ROE | -144.07% | 52W High | -27.31% ($94.57) | Perf Year | 385.8% |
| Cash/sh | 10.53 | P/FCF | - | Sales past 3/5Y | -69.79% - | ROIC | -109.61% | 52W Low | 536.19% ($10.81) | Perf 3Y | - |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -109.03% | Gross Margin | -86.29% | Volatility(W/M) | 5.86% 6.38% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | 681.11 | Sales Y/Y TTM | -19.26% | Oper. Margin | -11002.14% | ATR (14) | 4.81 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 4.49 | EPS Q/Q | 24.83% | Profit Margin | -11077.57% | RSI (14) | 39.28 | Recom | 3 |
| Dividend Gr. 3/5Y | - | Current Ratio | 4.49 | Sales Q/Q | - | SMA20 | -8.65% ($75.25) | Beta | 1.76 | Target Price | $12 |
| Payout | - | Debt/Eq | 2.9 | Earnings | 11000000 | SMA50 | -10.14% ($76.5) | Rel Volume | 0.65 | Prev Close | $69.3 |
| Employees | 161 | LT Debt/Eq | 2.84 | EPS/Sales Surpr. | -32.56% - | SMA200 | 37.36% ($50.04) | Avg Volume(3M) | 0.21M | Price | $68.74 |
| IPO | 2024/5/29 | Option/Short | Yes/Yes | Trades | 3790 | Volume | 137,687 | Change | -0.81% |
뉴스 로딩 중...